{"id":"https://openalex.org/W2007600985","doi":"https://doi.org/10.2174/1381612003400146","title":"Recent Developments in Receptor-Selective Retinoids","display_name":"Recent Developments in Receptor-Selective Retinoids","alternate_titles":[],"publication_year":2000,"publication_date":"2000-06-01","ids":{"openalex":"https://openalex.org/W2007600985","doi":"https://doi.org/10.2174/1381612003400146","mag":"2007600985","pmid":"https://pubmed.ncbi.nlm.nih.gov/10828316"},"language":"en","primary_location":{"id":"doi:10.2174/1381612003400146","doi":"https://doi.org/10.2174/1381612003400146","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1381612003400146","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2007600985"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063183571","display_name":"Sunil Nagpal","orcid":"https://orcid.org/0000-0001-6090-8780","observed_orcids":["https://orcid.org/0000-0001-6090-8780"]},"institutions":[{"id":"https://openalex.org/I4210139498","display_name":"Allergan (United States)","ror":"https://ror.org/03pfqk412","country_code":"US","type":"company","lineage":["https://openalex.org/I2948728702","https://openalex.org/I4210139498"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sunil Nagpal","raw_affiliation_strings":["Retinoid Research, Department of Biology and Chemistry, Allergan Inc., Irvine, CA-92713, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Retinoid Research, Department of Biology and Chemistry, Allergan Inc., Irvine, CA-92713, USA","institution_ids":["https://openalex.org/I4210139498"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111860565","display_name":"Roshantha A.S. Chandraratna","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Roshantha Chandraratna","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.6938,"has_fulltext":false,"cited_by_count":121,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.90675568,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"6","issue":"9","first_page":"919","last_page":"931"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/retinoic-acid-receptor","display_name":"retinoic acid receptor","score":0.9229999780654907},{"id":"https://openalex.org/keywords/retinoid-x-receptor","display_name":"retinoid X receptor","score":0.9879999756813049},{"id":"https://openalex.org/keywords/tazarotene","display_name":"tazarotene","score":0.9819999933242798},{"id":"https://openalex.org/keywords/adapalene","display_name":"adapalene","score":1.0},{"id":"https://openalex.org/keywords/retinoic-acid","display_name":"retinoic acid","score":0.7210000157356262},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.6620000004768372},{"id":"https://openalex.org/keywords/acne-vulgaris","display_name":"acne","score":0.968999981880188},{"id":"https://openalex.org/keywords/squamous-cell-carcinoma","display_name":"squamous cell carcinoma","score":0.7310000061988831},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.7160000205039978},{"id":"https://openalex.org/keywords/inverse-agonists","display_name":"inverse agonists","score":0.7200000286102295},{"id":"https://openalex.org/keywords/pml-gene","display_name":"PML gene","score":0.5199999809265137},{"id":"https://openalex.org/keywords/creb-binding-protein","display_name":"CREB-binding protein","score":0.8700000047683716},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.6449999809265137}],"concepts":[{"id":"https://openalex.org/C2779306117","wikidata":"https://www.wikidata.org/wiki/Q3981685","display_name":"Tazarotene","level":3,"score":0.9219616651535034},{"id":"https://openalex.org/C2775954498","wikidata":"https://www.wikidata.org/wiki/Q420418","display_name":"Retinoid","level":4,"score":0.8674803972244263},{"id":"https://openalex.org/C128821507","wikidata":"https://www.wikidata.org/wiki/Q3454518","display_name":"Retinoid X receptor","level":5,"score":0.6548582911491394},{"id":"https://openalex.org/C68484354","wikidata":"https://www.wikidata.org/wiki/Q17516011","display_name":"Retinoid X receptor alpha","level":5,"score":0.5558896660804749},{"id":"https://openalex.org/C2777673923","wikidata":"https://www.wikidata.org/wiki/Q79928","display_name":"Acne","level":2,"score":0.49722054600715637},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.49565255641937256},{"id":"https://openalex.org/C758759","wikidata":"https://www.wikidata.org/wiki/Q18031337","display_name":"Retinoid X receptor beta","level":5,"score":0.4860842525959015},{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.4767904281616211},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.47632962465286255},{"id":"https://openalex.org/C2778820923","wikidata":"https://www.wikidata.org/wiki/Q418192","display_name":"Bexarotene","level":5,"score":0.4759219288825989},{"id":"https://openalex.org/C2777140388","wikidata":"https://www.wikidata.org/wiki/Q352348","display_name":"Adapalene","level":5,"score":0.45371755957603455},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4261760711669922},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4194435775279999},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34294581413269043},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3108316659927368},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24367687106132507},{"id":"https://openalex.org/C63932345","wikidata":"https://www.wikidata.org/wiki/Q422500","display_name":"Nuclear receptor","level":4,"score":0.212417870759964},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.19118812680244446},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17623576521873474},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.07779806852340698},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C44228677","wikidata":"https://www.wikidata.org/wiki/Q181898","display_name":"Polymerization","level":3,"score":0.0},{"id":"https://openalex.org/C2778885487","wikidata":"https://www.wikidata.org/wiki/Q411424","display_name":"Benzoyl peroxide","level":4,"score":0.0},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068816","descriptor_name":"Adapalene","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009539","descriptor_name":"Nicotinic Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012176","descriptor_name":"Retinoids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012176","descriptor_name":"Retinoids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D014157","descriptor_name":"Transcription Factors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D014157","descriptor_name":"Transcription Factors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D014157","descriptor_name":"Transcription Factors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014157","descriptor_name":"Transcription Factors","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018168","descriptor_name":"Receptors, Retinoic Acid","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018168","descriptor_name":"Receptors, Retinoic Acid","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018168","descriptor_name":"Receptors, Retinoic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018168","descriptor_name":"Receptors, Retinoic Acid","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D047488","descriptor_name":"Retinoid X Receptors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/1381612003400146","doi":"https://doi.org/10.2174/1381612003400146","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1381612003400146","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},{"id":"pmid:10828316","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10828316","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current pharmaceutical design","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2024527855","https://openalex.org/W2065657808","https://openalex.org/W2141244074","https://openalex.org/W2298825694","https://openalex.org/W2172133791","https://openalex.org/W2420856930","https://openalex.org/W70952484","https://openalex.org/W4388244301","https://openalex.org/W2294164487","https://openalex.org/W2067085716"],"abstract_inverted_index":{"Natural":[0],"(all":[1],"trans-retinoic":[2],"acid,":[3,250],"RA)":[4],"and":[5,14,31,71,79,81,103,125,166,215,233],"synthetic":[6],"retinoids":[7,62,105,152,205],"exhibit":[8],"potent":[9],"anti-proliferative,":[10],"normalization":[11],"of":[12,53,60,87,116,122,141,173,192,197,203,211,217,219,235],"differentiation":[13],"anti-inflammatory":[15],"activities":[16],"which":[17,111],"appear":[18],"to":[19,92,129,170,186,224],"account":[20],"for":[21,55,77,84,119,179,229],"their":[22],"therapeutic":[23,238],"effects":[24,45],"in":[25,40,65,113,137,155,189,194,226],"acne,":[26],"psoriasis,":[27],"photoaging,":[28],"precancerous":[29],"lesions":[30],"established":[32],"cancers.":[33],"Although":[34],"RA":[35],"has":[36,63],"shown":[37],"considerable":[38],"promise":[39],"dermatologic":[41],"indications,":[42],"certain":[43],"side":[44],"have":[46,106],"restricted":[47],"its":[48],"use":[49],"as":[50,126],"a":[51],"choice":[52],"agent":[54],"chronic":[56],"administration.":[57],"Systematic":[58],"synthesis":[59,172],"receptor-selective":[61],"resulted":[64],"two":[66],"topical":[67],"drugs,":[68],"Tazorac/Zorac":[69],"(tazarotene)":[70],"Differin":[72,82,263],"(adapalene).":[73],"Tazorac":[74],"is":[75],"indicated":[76],"psoriasis":[78,124],"acne":[80],"gel":[83],"the":[85,93,120,171,190,212],"treatment":[86,121,191],"acne.":[88],"These":[89,109,182],"drugs":[90],"bind":[91],"retinoic":[94],"acid":[95,244],"receptor":[96,147],"(RAR)":[97],"family":[98],"members.":[99],"Various":[100],"RAR":[101,271,279],"subtype-specific":[102],"function-selective":[104],"been":[107],"synthesized.":[108],"retinoids,":[110,262],"are":[112,222],"various":[114],"stages":[115],"pre-clinical":[117],"development":[118],"cancers,":[123],"an":[127,208],"antidote":[128],"Accutane-mediated":[130],"mucocutaneous":[131],"toxicity,":[132],"will":[133],"also":[134],"be":[135,187],"discussed":[136],"this":[138],"review.":[139],"Discovery":[140],"another":[142],"retinoid":[143,145,156,220,237],"receptor,":[144,245,248],"X":[146,247],"(RXR),":[148],"revealed":[149],"that":[150],"RXR-specific":[151,174],"already":[153],"existed":[154],"chemical":[157],"libraries.":[158],"Structure":[159],"activity":[160],"relationship":[161],"studies":[162],"based":[163],"upon":[164],"binding":[165,284],"transactivation":[167],"assays":[168],"led":[169],"ligands":[175],"with":[176,207],"high":[177],"affinities":[178],"RXR":[180],"subtypes.":[181],"compounds":[183],"were":[184],"found":[185],"effective":[188],"hyperglycemia":[193],"animal":[195],"models":[196],"type":[198],"II":[199],"diabetes.":[200],"The":[201],"discovery":[202],"novel":[204],"along":[206],"increased":[209],"understanding":[210],"biological":[213],"functions":[214],"mechanisms":[216],"action":[218],"receptors":[221],"likely":[223],"result":[225],"improved":[227],"treatments":[228],"existing":[230],"responsive":[231],"indications":[232],"identification":[234],"new":[236],"targets.":[239],"Keywords:":[240],"Adpalene,":[241],"Tazarotene,":[242],"Retinoic":[243,249],"Retinoid":[246],"Squamous":[251],"cell":[252],"carcinoma,":[253],"Pan":[254],"agonists,":[255,282],"Induced":[256],"genes,":[257,259],"Repressed":[258],"Receptor":[260],"selective":[261],"(Adapalene":[264],"CD":[265],"271),":[266],"Human":[267],"polymorphonuclear":[268],"(PMN)":[269],"leukocytes,":[270],"alpha":[272],"specific":[273],"Retinoids,":[274],"Promyelocytic":[275],"leukemia":[276],"(PML)":[277],"gene,":[278],"antagonists":[280],"inverse":[281],"CREB":[283],"protein":[285]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2007600985","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
